Summit Securities Group’s AN2 Therapeutics ANTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,000
Closed -$33K 443
2024
Q1
$33K Buy
+10,000
New +$33K 0.01% 158